Accurate adiposity measurements key to tackling obesity-related diseases, study finds

FHS
July 17, 2024
2:47 am

Accurate adiposity assessment is critical for understanding obesity-related disease risks, but current clinical measurement methods have significant limitations.

Novo Nordisk signs $285m deal with Ascendis to create once-monthly GLP-1RA – Pharmaceutical Technology

The Danish companies aim to jointly develop a GLP-1RA administered once a month. Credit: Kittyfly / Shutterstock Novo Nordisk and Ascendis Pharma have agreed to

November 5, 2024

A comparison of the lived experiences among extended and long-term young adult cancer survivors

Researchers compared the life experiences of young adult (YA) cancer survivors aged 18 to 39.

July 18, 2023

Virgin Pulse, AWS Accelerate Homebase for Health Innovation

What You Should Know: – Virgin Pulse announced a long-term initiative with Amazon Web Services (AWS) to support the innovation, growth, and performance of Virgin

October 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.